DNA-binding properties of hPOMp100/PSF. (A) Varying concentrations of hPOMp100/PSF were incubated with either 64 nM 32P-labelled 49mer oligonucleotide (lanes 1–7) or 64 nM 32P-labelled 49-bp ds-oligonucleotide (lanes 8–13). Concentrations of hPOMp100 were 0.1, 0.2, 1, 2, 10 and 20 nM (lanes 2–7) and 2, 5, 10, 20 and 40 nM (lanes 9–13). (B) 2 (lane 2) or 10 nM (lanes 3–9) hPOMp100/PSF were incubated with 64 nM 32P-labelled 49mer oligonucleotide in the absence (lanes 2 and 3) or in the presence of 25-, 50- or 100-fold molar excess of unlabelled ds- (lanes 4–6) or in the presence of 10-, 25- or 50-fold molar excess of unlabelled ssφX174 DNA (lanes 7–9). (C) 10 (lanes 2, 6, 10 and 14), 20 (lanes 3, 7, 11 and 15) or 40 nM (lanes 4, 8, 12 and 16) hPOMp100/PSF were incubated with 60 nM 32P-labelled 19 (lanes 1–4), 24 (lanes 5–8), 49 (lanes 9–12) or 60mer (lanes 13–16) oligonucleotides. The left part of the gel (lanes 1–8) was exposed 3 times longer than the right part (lanes 9–16) in order to detect a comparable amount of protein–DNA complexes. Protein–DNA complexes were analysed by native 6% PAGE. no, no protein was added.